13:56 23.03.2016

Low cash cost, high quality attract intl pharmaceutical company to production in India – ambassador

2 min read
Low cash cost, high quality attract intl pharmaceutical company to production in India – ambassador

Low cost, high quality pharmaceutical producers in India attract investment in India, Ambassador Extraordinary and Plenipotentiary of India to Ukraine Manoj Kumar Bharti said at a press conference at Interfax-Ukraine on Tuesday.

All multinational pharmaceutical companies are present in India, he said. The main argument for their presence in the country is advantages in workforce and the cash cost, the ambassador said.

He said Indian pharmaceutical products are used around the globe.

Indian pharmaceutical products are known by their high quality and fair price. They pass the red tape filters of strict regulatory agencies in India. This means that the products comply with Ukrainian standards as well, he said.

Bharti added that Indian pharmaceutical products are in great demand at the United Nations, by the UNDP and UNICEF, which buy products of Indian manufacturers because they have advantages compared to manufacturers from other countries.

He said that before the medicines are registered in Ukraine, GMP inspectors visit production facilities in India. The products are also tested in Ukrainian laboratories.

If there are questions to Indian pharmaceutical companies when their products came to the Ukrainian market, this is not a question for pharmaceutical manufacturers, but for Ukraine, he said.

Commenting on complaints of experts about some Indian medicines recommended for purchase by international organizations, Bharti said that they are not fair.

"If the medicine was first registered in Ukraine by public authorities and later removed by so-called experts it is unfair. We will fight against this," the ambassador said.

Ukraine imported $114 million worth of pharmaceutical products from India in 2015.

AD
AD
AD
AD
AD